Drug Maker Says Women Can Now Access Postpartum Depression Pill

Follow Drugslib on

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Dec. 15, 2023 -- Zurzuvae (zuranolone), the first postpartum depression pill approved for use in the United States, is now available to women who need it. The medication, which is now stocked in specialty pharmacies, can also be shipped directly to patients, Biogen and Sage Therapeutics Inc. said in a news release Thursday.

"Having an option like Zurzuvae that can work at day 15 and improve symptoms in as early as three days has the potential to make a profound difference in the lives of women with PPD [postpartum depression]," Kristina Deligiannidis, M.D., a professor at the Feinstein Institutes for Medical Research in New York City who has been the lead investigator on the clinical trials that led to Zurzuvae's approval, said in the company news release.

However, the treatment is not inexpensive: The medication will cost ,900 per course before insurance.

Taken as a pill once a day for two weeks, Zurzuvae showed "rapid, significant, and sustained" reductions in depressive symptoms when compared to a placebo, according to a recent study of nearly 200 women, the FDA noted when it approved the medication back in August.

"Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness -- even, in severe cases, thoughts of harming themselves or their child," Tiffany Farchione, M.D., director of the Division of Psychiatry in the FDA Center for Drug Evaluation and Research, said in an agency news release announcing the approval. "And, because postpartum depression can disrupt the maternal-infant bond, it can also have consequences for the child's physical and emotional development."

The most common side effects with Zurzuvae were sleepiness, dizziness, sedation, and headache. Because of the danger of sedation, the FDA has put a black box warning on Zurzuvae's labeling, cautioning that users should not drive or operate heavy machinery within 12 hours of taking the pill.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-16 06:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords